Lilly (Organization)

Indiana, Eli Lilly to partner to bring nuclear power to the state
Nuclear is seen as key to AI energy needs, but it's years away from large-scale viability.
Axios 3 min read
FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill
At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be linked to liver, heart and gastrointestinal problems
The Independent UK 4 min read
The Next Big AI Winner Might Not Be a Tech Company
Lilly’s AI push shows how non-tech firms can dominate the next wave.
Barchart 5 min read
Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience
Eli Lilly is securing its future by investing in AI drug discovery and expanding its pipeline into the multi-billion-dollar neuroscience market.
MarketBeat 7 min read
Foundayo vs Zepbound: How Eli Lilly’s new weight loss pill compares to its injectable
IN FULL
The Independent UK 2 min read
Eli Lilly Pops on GLP-1 Pill Approval. Should You Buy LLY Stock Here?
Eli Lilly stock rallies as the firm’s oral weight-loss pill, Foundayo, secures FDA approval. Options pricing suggests LLY shares will rip higher over the next three months.
Barchart 3 min read
US approves new oral weight-loss pill developed by Eli Lilly
Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy
The Guardian - US 3 min read
Foundayo: All you need to know about the newly approved weight-loss pill
The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times
The Independent UK 3 min read
Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8B in Sleep Drug Mega-Deal, CNTA Stock Soaring 45%
Shares of Centessa Pharmaceuticals plc skyrocketed more than 44% Tuesday after the clinical-stage biotech announced it would be acquired by pharmaceutical giant Eli Lilly and Co. in a deal valued at up to $7.8 billion, giving Lilly a promising pipeline of experimental treatments for sleep-wake disorders.
International Business Times 9 min read
Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit?
Eli Lilly has expanded its partnership with Insilico Medicine to bring AI developed medicine into global market.
Barchart 5 min read